Innate immunity symposium convened at UMMS

Toll-like receptor research pioneer Golenbock guest of honor at international gathering

UMass Medical School Communications

July 30, 2014

Douglas Golenbock, MD, PhDThe Department of Medicine’s Program in Innate Immunity hosted a symposium in honor of Douglas Golenbock, MD, PhD. Much of Dr. Golenbock’s pioneering research into Toll-like receptors (TLRs) has been conducted with, and inspired by, the colleagues who gathered at UMMS on Friday, July 25, to talk about science and celebrate his 60th birthday.

Members of the international innate immunity research community of which Dr. Golenbock (at right), professor of medicine and chief of the Division of Infectious Diseases and Immunology, is a founding member, convened for the symposium. The full-day program featured presentations from:

  • Terje Espevik, PhD, of the Norwegian University of Science and Technology
  • Randy Hampton, PhD, of the University of California San Diego
  • Holger Heine, PhD, of the Research Center Borstel at the Leibniz Center for Medicine and Biosciences, Germany
  • Amy Hise, MD, MPH, of Case Western Reserve University School of Medicine
  • Robin Ingalls, MD, of the Boston University School of Medicine
  • Eicke Latz, MD, of UMass Medical School
  • Luke O’Neill, PhD, of Trinity College Dublin, Ireland
  • Andra Schromm, PhD, of the Research Center Borstel at the Leibniz Center for Medicine and Biosciences, Germany
  • Stefanie Vogel, PhD, of the University of Maryland School of Medicine
  • Donghai Wang, PhD, of UMass Medical School.

Golenbock is a leader in the emerging field of TLR research. Since coming to UMMS in 2001, he has conducted frequently cited, high-impact studies related to microbial recognition by the host, innate immunity, TLRs and inflammasome biology.